Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Figure FS7 from Allogeneic CAR T Cells Targeting DLL3 Are Efficacious and Safe in Preclinical Models of Small Cell Lung Cancer
  1. Home
  2. Publications
  3. Figure FS7 from Allogeneic CAR T Cells Targeting DLL3 Are Efficacious and Safe in Preclinical Models of Small Cell Lung Cancer

Figure FS7 from Allogeneic CAR T Cells Targeting DLL3 Are Efficacious and Safe in Preclinical Models of Small Cell Lung Cancer

Authors:
  • YZYi Zhang
    Yi Zhang
  • STSilvia K. Tacheva-Grigorova
    Silvia K. Tacheva-Grigorova
  • JSJanette Sutton
    Janette Sutton
  • ZMZea Melton
    Zea Melton
  • YMYvonne S.L. Mak
    Yvonne S.L. Mak
  • CLCecilia Lay
    Cecilia Lay
  • BSBryan A. Smith
    Bryan A. Smith
  • TSTao Sai
    Tao Sai
  • TBThomas Van Blarcom
    Thomas Van Blarcom
  • BSBarbra J. Sasu
    Barbra J. Sasu
  • SPSiler H. Panowski
    Siler H. Panowski

Open Access
Publisher website
Google Scholar
  • 25 November 2025
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1078-0432.30707795
Abstract
Fig. S7. DLL3 CAR T cells demonstrate activity in intracranial tumor model without causing toxicity.
Keywords
  • IMMUNOTHERAPY
  • CELLULAR IMMUNOTHERAPY
  • ENGINEERED/CAR T CELLS
  • TOXICITIES/IRAES
  • LUNG CANCER
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.